(lp0
S'On March 16, Threshold and Molecular Templates announced their merger, to be ... Seeking Alpha - Mar 20, 2017 If all goes as planned, there will not be a Threshold Pharmaceuticals Inc.  for much longer. On March 16, Threshold announced that it will be joining in an all stock merger with privately held Molecular Templates, and the new company will ...What Does The Merger News Mean For Threshold Pharmaceuticals Inc (NASDAQ:THLD ... - Insider FinancialAnalysts mean rating score stands at 2.00 while Threshold Pharmaceuticals, Inc ... - Hot Stocks Point'
p1
aS"Friday's Market Insights: Threshold Pharmaceuticals, Inc. , Innocoll ... Smarter Analyst - Mar 17, 2017 Threshold Pharmaceuticals, Inc.  shares are rising 19% in Friday's trading session, after the drug maker announced that it has entered into a definitive agreement under which Molecular Templates will merge with a wholly owned subsidiary of&nbsp;...Threshold Pharmaceuticals and Molecular Templates Agree to Combine - GlobeNewswire Threshold Pharma, Molecular Templates to Merge  - Investopedia"
p2
aS'BRIEF-Threshold Pharmaceuticals and Molecular Templates agree to combine Reuters - Mar 17, 2017 March 17 Threshold Pharmaceuticals Inc. * Threshold Pharmaceuticals and Molecular Templates agree to combine. * Threshold Pharmaceuticals Inc says combined company will be capitalized to support advancement of MT-3724. * Longitude Capital will&nbsp;...'
p3
aS'Revenue Approximations Analysis: Mueller Water Products, Inc. , Threshold ... StockNewsJournal - 15 hours ago Threshold Pharmaceuticals, Inc. , at its latest closing price of $0.58, it has a price-to-book ratio of 1.97, compared to an industry average at 10.15.'
p4
aS"Threshold Pharma  Says Two Studies Didn't Meet Activity Thresholds ... StreetInsider.com - Sep 29, 2016 On September 29, 2016, the Compensation Committee of the Board of Directors  of Threshold Pharmaceuticals, Inc.  committed to implementing a workforce reduction constituting approximately&nbsp;...Is There Value In The Threshold Pharmaceuticals, Inc.  Sell Off? - Market Exclusive"
p5
aS'Analysts Weigh in on Two Collapsing Biotech Stocks: Threshold Pharmaceuticals ... Smarter Analyst - Sep 30, 2016 The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc.  and word from the FDA to place a drug program on full clinical hold for Alcobra Ltd (NASDAQ:ADHD ...'
p6
aS'Threshold Pharmaceuticals, Inc.  Might Just Have Become A Buyout ... Insider Financial - Oct 5, 2016 Threshold Pharmaceuticals, Inc.  collapsed last week on the announcement that its lead trial had missed its primary endpoint.'
p7
aS"Sell-side Consensus Sees Threshold Pharmaceuticals, Inc.  Going ... Aiken Advocate - 11 hours ago Investors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability."
p8
aS'Threshold Pharmaceuticals: Twice Bitten, Thrice Shy? Seeking Alpha - Nov 28, 2016 Threshold Pharmaceuticals Inc  is a biopharmaceutical company in operation since the mid 2000s, with projects in the tumor/cancer treatment environment.'
p9
aS'Investor Chatter: Tracking Technical Indicators for Threshold Pharmaceuticals ... Midway Monitor - 9 hours ago Technical analysts may be interested in how Threshold Pharmaceuticals Inc  is trading in relation to some moving averages.'
p10
a.